• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About
    • About Us
    • Founding Team
  • Blog
  • Drug Search
  • Zones
    • Suicide
    • Violence
    • Sex and Relationships
    • Hair
    • Skin and Nails
    • Withdrawal
    • Vision
    • Fertility
  • Research Fund
  • Tools
    • Healthcare Record Pro Forma
    • Starting a Medication
    • Guides & Papers
    • Too Many Medications?
    • Complex Withdrawal
    • Videos
    • Reducing the Risk of Treatment Induced Suicide
  • PSSD
    • Post-SSRI Sexual Dysfunction (PSSD)
    • PSSD Doctors
    • PSSD Literature
    • PSSD in the Media
    • RxISK Prize
    • Research Forum for Enduring Sexual Dysfunction
  • Side Effect?
RxISK Logo

RxISK

Making Medicines Safer for All of Us

Drug Search by Year (Detail)

Side effect search by year (detail)

Drug:

Reaction: PRODUCT DOSE OMISSION ISSUE

20260101 - 20261231

No. 1 - 100

Next page: 2 next page>>
No.
safetyreportid
occurcountry
patientonsetage
patientsex 1:M 2:F
Adverse reaction
Drug (openfda.generic_name, medicinalproduct)
1
26940079
AU
Device deployment issue, Product dose omission issue,
GOLIMUMAB,
2
26940092
US
75 2
Needle issue, Accidental exposure to product, Device leakage, Feeling abnormal, Product dose omission issue,
GUSELKUMAB,
3
26940254
US
69
Device malfunction, Product dose omission issue,
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO,
4
26940273
AU
2
Device deployment issue, Product dose omission issue,
GOLIMUMAB,
5
26940297
US
Product dose omission issue,
GUSELKUMAB,
6
26940313
US
66 2
Dry mouth, Somnolence, Illness, Abdominal discomfort, Headache, Nausea, Dyspnoea, Fatigue, Product administered at inappropriate site, Product dose omission issue,
ABALOPARATIDE, ROSUVASTATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, CETIRIZINE HYDROCHLORIDE, SPIRONOLACTONE, NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION, 0.02%/0.005%,
7
26940326
US
2
Feeling abnormal, Dizziness, Product dose omission issue, Product colour issue,
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE,
8
26940337
US
58
Infection, Abscess, Eczema, Product dose omission issue,
9
26940339
US
1
Product dose omission issue,
GUSELKUMAB,
10
26940340
US
53 2
Product dose omission issue,
LENALIDOMIDE,
11
26940358
US
2
Spinal stenosis, Injection site bruising, Pain in extremity, Headache, Pain, Bone pain, Product dose omission issue, Extra dose administered,
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, CYCLOBENZAPRINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE,
12
26940361
US
2
Adverse drug reaction, Rash, Fatigue, Headache, Needle issue, Needle issue, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, CALCIUM, ERGOCALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, VITAMIN C, CYANOCOBALAMIN, BUPROPION, ALPRAZOLAM, SERTRALINE,
13
26940382
US
2
Injection site discomfort, Chest pain, Pain in jaw, Urine odour abnormal, Anxiety, Injection site pain, Injection site reaction, Injection site bruising, Dizziness, Headache, Arthralgia, Bone pain, Product distribution issue, Product dose omission in error, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TOPIRAMATE,
14
26940391
US
2
Adverse event, Headache, Product dose omission issue,
ABALOPARATIDE,
15
26940406
US
81 1
Drug delivery system malfunction, No adverse event, Product dose omission issue,
TOCILIZUMAB,
16
26940430
US
2
Injection site urticaria, Muscle spasms, Pain in extremity, Injection site pruritus, Nausea, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, GABAPENTIN, LISINOPRIL, PYRIDOSTIGMINE BROMIDE,
17
26940476
US
2
Abdominal discomfort, Heart rate increased, Nausea, Headache, Palpitations, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE,
18
26940524
US
2
Nodule, Dizziness, Arthralgia, Product dose omission issue,
ABALOPARATIDE,
19
26940560
US
2
Knee operation, Injection site haematoma, Constipation, Injection site bruising, Injection site erythema, Palpitations, Incorrect dose administered, Off label use, Product dose omission issue, Product administration interrupted,
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, CELECOXIB, CELECOXIB, STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM,
20
26940588
US
2
Product dose omission issue, Product availability issue,
ABALOPARATIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FLUOXETINE HYDROCHLORIDE, HYDROXYZINE, MELOXICAM, PREGABALIN, ROPINIROLE,
21
26940619
US
2
Upper limb fracture, Product dose omission issue,
ABALOPARATIDE,
22
26940620
US
2
Tinnitus, Muscular weakness, Chest pain, Hypoaesthesia, Paraesthesia, Headache, Dizziness, Fatigue, Product dose omission issue,
ABALOPARATIDE, ROSUVASTATIN,
23
26940665
US
1
Injection site reaction, Therapy interrupted, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE,
24
26940681
US
44 2
Uterine leiomyoma, Product dose omission issue,
ASFOTASE ALFA, ASFOTASE ALFA,
25
26940685
US
Keratomileusis, Visual impairment, Product dose omission issue, Corrective lens user, Wrong technique in product usage process,
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE,
26
26940715
US
2
Influenza like illness, Unevaluable event, Dizziness, Heart rate increased, Back pain, Injection site bruising, Arthralgia, Headache, Fatigue, Product dose omission issue, Intentional dose omission,
ABALOPARATIDE, ABALOPARATIDE,
27
26940747
US
2
Dysgeusia, Heart rate increased, Product dose omission issue,
ABALOPARATIDE,
28
26940809
US
2
Abdominal discomfort, Constipation, Palpitations, Fatigue, Asthenia, Cardiac disorder, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUOXETINE HYDROCHLORIDE, GABAPENTIN, LOSARTAN POTASSIUM, LOSARTAN, MAGNESIUM, MELATONIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, TIOTROPIUM BROMIDE, ERGOCALCIFEROL,
29
26940825
US
2
Abdominal discomfort, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE,
30
26940855
US
81 2
Muscle twitching, Vulvovaginal discomfort, Product dose omission issue,
ABALOPARATIDE, THYROID, PORCINE,
31
26940891
US
2
Dyspnoea, Product dose omission issue,
TREPROSTINIL, TREPROSTINIL, AMBRISENTAN, FAMOTIDINE, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), RIFAXIMIN, MAGNESIUM, AIRBORNE, FUROSEMIDE, AZELASTINE HYDROCHLORIDE, AZELASTINE, TADALAFIL, ALBUTEROL SULFATE, ROSUVASTATIN, ALPRAZOLAM, OXYGEN, 0XYGEN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, COLESTIPOL HYDROCHLORIDE, DIGOXIN, ONDANSETRON HYDROCHLORIDE, ZOLPIDEM TARTRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CETIRIZINE HYDROCHLORIDE,
32
26940978
GB
61
Rheumatoid arthritis, Product prescribing issue, Product dose omission issue,
ADALIMUMAB-AATY, ADALIMUMAB-AATY,
33
26940979
US
2
Urinary tract infection, Headache, Dizziness, Nausea, Product dose omission issue,
ABALOPARATIDE,
34
26940986
US
2
Presyncope, Paraesthesia, Brain fog, Sensory disturbance, Injection site discomfort, Upper-airway cough syndrome, Respiratory tract infection, Nasopharyngitis, Vertigo, Dizziness, Muscle spasms, Nausea, Headache, Fatigue, Injection site pain, Injection site bruising, Constipation, Abdominal pain upper, Abdominal distension, Malaise, Pain in extremity, Diarrhoea, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, ROSUVASTATIN,
35
26941011
US
2
Abdominal distension, Weight increased, Constipation, Malaise, Nausea, Vomiting, Diarrhoea, Dizziness, Product dose omission issue,
ABALOPARATIDE,
36
26941040
US
75 2
Oropharyngeal pain, Productive cough, Fall, Tooth fracture, Device defective, Product dose omission issue, Device issue, Injury associated with device,
ABALOPARATIDE,
37
26941063
US
1
Product distribution issue, Product dose omission issue,
ABALOPARATIDE,
38
26941065
US
1
Somnolence, Fatigue, Abdominal pain upper, Diarrhoea, Product dose omission issue, Product dose omission in error,
ABALOPARATIDE, ABALOPARATIDE,
39
26941072
US
2
Migraine, Product dose omission issue,
ABALOPARATIDE,
40
26941082
US
2
Myalgia, Brain fog, Disturbance in attention, Feeling abnormal, Dizziness, Arthralgia, Muscle spasms, Fatigue, Back pain, Headache, Nausea, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, CALCIUM, FAMOTIDINE, PANTOPRAZOLE, ROSUVASTATIN, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE,
41
26941095
US
36
Dermatitis atopic, Product dose omission issue,
NEMOLIZUMAB-ILTO,
42
26941099
US
2
Vitamin D deficiency, Blood pressure fluctuation, Feeling abnormal, Tachycardia, Blood pressure increased, Heart rate increased, Palpitations, Injection site pain, Injection site bruising, Headache, Accidental overdose, Product dose omission issue, Circumstance or information capable of leading to medication error,
ABALOPARATIDE,
43
26941117
US
70 2
Somnolence, Blood pressure decreased, Fatigue, Device failure, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE,
44
26941133
US
2
Abdominal hernia, Injection site pain, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, CELECOXIB,
45
26941174
US
2
Spinal pain, Paraesthesia, Cardiovascular symptom, Grip strength decreased, Injection site urticaria, Purpura, Blood pressure increased, Heart rate increased, Dizziness, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE,
46
26941175
US
2
Scoliosis, Fall, Dyspnoea, Device issue, Product dose omission issue,
ABALOPARATIDE,
47
26941177
US
38 1
Product temperature excursion issue, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE,
48
26941224
CN
1
Device deployment issue, Product dose omission issue, Accidental exposure to product,
GOLIMUMAB,
49
26941330
RU
2
Device defective, Off label use, Product dose omission issue,
USTEKINUMAB, USTEKINUMAB,
50
26941340
US
Gastrointestinal disorder, Abdominal distension, Menstruation irregular, Product dose omission issue,
NORGESTIMATE AND ETHINYL ESTRADIOL,
51
26941386
US
54
Product dose omission issue,
EPTINEZUMAB-JJMR,
52
26941398
US
2
Device defective, Product dose omission issue,
GUSELKUMAB,
53
26941461
US
2
Anxiety, Chest pain, Heart rate increased, Dizziness, Fatigue, Headache, Arthralgia, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NAPROXEN, NAPROXEN SODIUM, FLUOXETINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, VITAMIN E,
54
26941464
US
59 2
Myalgia, Nausea, Heart rate increased, Headache, Bone pain, Arthralgia, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, PROGESTERONE, TEMAZEPAM, ERGOCALCIFEROL,
55
26941475
US
2
Constipation, Dizziness, Irritable bowel syndrome, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, MAGNESIUM, POLYETHYLENE GLYCOL 3350, VITAMIN C,
56
26941486
US
2
Illness, Fatigue, Lethargy, Therapeutic response unexpected, Product dose omission issue,
ABALOPARATIDE,
57
26941515
US
2
Hypoacusis, Decreased appetite, Product dose omission issue,
ABALOPARATIDE,
58
26941524
KH
2
Cholelithiasis, Chronic myeloid leukaemia, Malignant neoplasm progression, Vaginal haemorrhage, Uterine haemorrhage, Haematochezia, Hypothyroidism, Malaise, Diabetes mellitus, Loose tooth, Blood creatinine decreased, Varicose vein, Drug intolerance, Cardiac disorder, Crying, Transferrin saturation decreased, Blood cholesterol increased, Microalbuminuria, White blood cell count increased, Prothrombin time shortened, Blood lactate dehydrogenase abnormal, Lymphocyte count abnormal, Antinuclear antibody positive, Blood triglycerides increased, Product dose omission issue, Iron deficiency anaemia, Alanine aminotransferase abnormal, Aspartate aminotransferase abnormal, Manganese increased, Neutrophil count increased, Mean cell haemoglobin concentration abnormal, Neck pain, Back pain, Pallor, Ocular hyperaemia, Pain, Peripheral swelling, Oedema peripheral, Normochromic normocytic anaemia, Hepatomegaly, Dyslipidaemia, Hyperglycaemia, Hepatic steatosis, Arthralgia, Pain in extremity, Chest pain, Haemoglobin decreased, Anaemia, Dyspnoea, Anxiety, Tachycardia, White blood cell count abnormal, Cough, Blood pressure increased, Blood iron decreased, Cytogenetic analysis abnormal, Hypertension, Depression,
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NILOTINIB, DICLOFENAC, DICLOFENAC SODIUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, CALCIUM,
59
26941568
US
48 1
Needle issue, Product dose omission issue, Accidental exposure to product,
GUSELKUMAB,
60
26941573
US
43
Dermatitis atopic, Device malfunction, Product dose omission issue,
NEMOLIZUMAB-ILTO,
61
26941595
US
2
Pyrexia, Dizziness, Injection site reaction, Diarrhoea, Pain, Insomnia, Pain in extremity, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, GLIMEPIRIDE, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HYDROCLORIDE, MIRABEGRON, PIOGLITAZONE, PREGABALIN, TERBINAFINE HYDROCHLORIDE, TERBINAFINE, TERBINAFINE HYDROCHLORIDE TABLET,
62
26941599
US
2
Adverse event, Heart rate increased, Liquid product physical issue, Product dose omission issue, Product use issue, Device failure,
ABALOPARATIDE,
63
26941600
US
2
Gingival abscess, Headache, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,,
64
26941602
US
64 2
Impaired driving ability, Condition aggravated, Fall, Dizziness, Fatigue, Product dose omission issue,
ABALOPARATIDE,
65
26941605
US
61 2
Sinus headache, Urinary tract infection, Feeling abnormal, Dizziness, Fatigue, Palpitations, Product dose omission issue, Product administered at inappropriate site,
ABALOPARATIDE, ABALOPARATIDE, CARVEDILOL, CYANOCOBALAMIN, SPIRONOLACTONE,
66
26941621
US
81 2
Product dose omission issue,
MAVACAMTEN,
67
26941622
US
2
Biopsy skin, Wound, Back pain, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, EVOLOCUMAB, ROSUVASTATIN,
68
26941640
US
2
Fat tissue increased, Injection site mass, Hypotension, Swelling, Abdominal distension, Dizziness, Headache, Injection site reaction, Heart rate increased, Blood calcium increased, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, ERGOCALCIFEROL,
69
26941681
US
2
Injury corneal, Paraesthesia, Dizziness, Arthralgia, Bone pain, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE,
70
26941719
US
79
Injection site haemorrhage, Device malfunction, Product dose omission issue,
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO,
71
26941742
US
Manufacturing product shipping issue, Product dose omission issue, No adverse event, Product packaging issue, Product physical issue, Product container seal issue,
SITAGLIPTIN,
72
26941749
US
2
Hospitalisation, Emergency care, Spinal pain, Musculoskeletal pain, Injection site pain, Product dose omission issue, Product use issue,
ABALOPARATIDE,
73
26941790
US
2
Muscular weakness, Muscle spasms, Pain in extremity, Product dose omission issue,
ABALOPARATIDE,
74
26941793
US
2
Foot fracture, Bone development abnormal, Heart rate increased, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE,
75
26941821
US
82
Device malfunction, Product dose omission issue,
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO,
76
26941823
US
2
Muscle twitching, Somnolence, Dizziness postural, Nocturia, Orthostatic hypertension, Depressed mood, Depression, Amnesia, Pollakiuria, Mood altered, Decreased appetite, Fatigue, Palpitations, Heart rate increased, Dizziness, Diarrhoea, Insomnia, Asthenia, Arthralgia, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE,
77
26941834
US
2
Intentional product use issue, Product dose omission issue,
ABALOPARATIDE,
78
26941835
US
2
Dyspepsia, Crepitations, Palpitations, Injection site pain, Wrong technique in product usage process, Product dose omission issue, Product communication issue,
ABALOPARATIDE, SIMVASTATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM,
79
26941837
US
2
Adverse drug reaction, Product dose omission issue,
ABALOPARATIDE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, CALCIUM, FOLIC ACID, OXYBUTYNIN, VALSARTAN, VALSARTAN ORAL, CYANOCOBALAMIN,
80
26941886
US
2
Spinal pain, Headache, Product dose omission issue,
ABALOPARATIDE,
81
26941894
US
2
Contusion, Injection site pain, Product dose omission issue, Product use issue,
ABALOPARATIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE,
82
26941901
US
64 2
Hypertension, Pain, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE,
83
26941904
AE
2
Rheumatoid arthritis, Product dose omission issue, Therapy interrupted,
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP,
84
26941909
US
28 2
Product dose omission issue, Product complaint,
MEPOLIZUMAB,
85
26941935
US
78
Device use error, Product dose omission issue, Intentional product use issue,
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, LEVOTHYROXINE SODIUM,
86
26941969
JP
53 2
Physical deconditioning, Dehydration, Renal impairment, Feeding disorder, Product dose omission issue, Off label use,
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE,
87
26942031
US
2
Memory impairment, Product dose omission issue,
ABALOPARATIDE,
88
26942041
US
67 2
Product dose omission issue, Product use issue, Product supply issue,
ABALOPARATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG,
89
26942186
CA
20
Rectal haemorrhage, Condition aggravated, Frequent bowel movements, Weight decreased, Weight increased, Off label use, Product dose omission issue, Inappropriate schedule of product administration,
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB,
90
26942190
US
Product dose omission issue, Device malfunction,
NEMOLIZUMAB-ILTO,
91
26942193
US
72 2
Weight decreased, Product dose omission issue,
ABALOPARATIDE, ABALOPARATIDE,
92
26942215
US
Syringe issue, Product dose omission issue,
GUSELKUMAB,
93
26942242
US
Product dose omission issue, Device delivery system issue,
94
26942334
GB
78 2
Rectal haemorrhage, Product dose omission issue,
BENRALIZUMAB, BENRALIZUMAB,
95
26942357
CA
2
Foot fracture, Lung neoplasm malignant, Rib fracture, Fall, Spinal fracture, Sternal fracture, Compression fracture, Body height decreased, Product dose omission issue,
DENOSUMAB, DENOSUMAB,
96
26942381
US
1
Product dose omission issue, Psychiatric decompensation,
97
26942394
US
2
Infection, Product dose omission issue,
OCTREOTIDE ACETATE, OCTREOTIDE,
98
26942402
US
71
Malaise, Device use error, Product dose omission issue,
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO,
99
26942437
US
71 1
Product dose omission issue,
DUPILUMAB,
100
26942501
CN
44 2
Needle issue, Product dose omission issue, Off label use,
GUSELKUMAB,

disclaimer

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.

terms

https://open.fda.gov/terms/

license

https://open.fda.gov/license/

last_updated

2026-07-30

Next page: 2 next page>>

Primary Sidebar

Recent Posts

  • The Troubled Dream of Life
  • Drug Induced Loss of Capacity
  • Consent to Waltz, Capacity to Tango, Connect to..
  • Ordinary or Forgotten Women and Men
  • Prescribed Harm Awareness Goes Global

Blog Categories

Footer

Contact

Media Contact

Terms | Privacy

Follow us

  • Facebook
  • Twitter

Search

Copyright © 2026 ยท Data Based Medicine Global Ltd.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.